Science Explorer Interactive view Map
Company · Milan · Italy

MolMed (Italy)

Research works
79
▼ 79% vs 2013–17
Citations
3.5k
43.7 per fractional work
Top-10% rate
6.7%
record average 16.5%
Open access
41%
world 28%

Not ranked overall: MolMed (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at MolMed (Italy)?

Ranked on the composite score, Catia Traversari lead among researchers whose main affiliation is MolMed (Italy).

  1. 1 Catia Traversari Italy · #1,026,153 worldwide 49 citations · 25 works
All ranked researchers at MolMed (Italy)

Which keywords describe research at MolMed (Italy)?

By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Gene Therapy, Cancer Immunotherapy, Genomic Integration, AAV, Viral Vectors, Tumor Regression and Cancer Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy13▲ 25×10 topics
  2. Gene Therapy12▲ 58×3 topics
  3. Cancer Immunotherapy9▲ 82×2 topics
  4. Genomic Integration9▲ 106×2 topics
  5. AAV9▲ 166×1 topic
  6. Viral Vectors9▲ 166×1 topic
  7. Tumor Regression8▲ 115×2 topics
  8. Cancer Therapy7▲ 14×7 topics
  9. Lymphoma7▲ 61×3 topics
  10. CAR T Cells7▲ 203×1 topic
  11. Chimeric Antigen Receptor7▲ 203×1 topic
  12. Leukemia7▲ 135×2 topics
  13. Angiogenesis7▲ 21×5 topics
  14. Tumor Microenvironment7▲ 23×5 topics
  15. Immunosuppression6▲ 66×3 topics
  16. PET Imaging6▲ 32×3 topics
  17. Stromal Cells5▲ 74×2 topics
  18. Fibroblast Activation Protein5▲ 129×1 topic
  19. N-terminal Acetylation5▲ 129×1 topic
  20. Glycosylation5▲ 26×3 topics
  21. Chemotherapy4▲ 8.1×11 topics
  22. NK Cell Recognition4▲ 48×1 topic
  23. Natural Killer Cells4▲ 48×1 topic
  24. Monoclonal Antibody4▲ 67×2 topics
  25. Biopharmaceutical Production4▲ 57×2 topics
  26. Prognostic Factors4▲ 9.7×5 topics
  27. Cell Culture3▲ 39×2 topics
  28. Targeted Therapy3▲ 20×5 topics
  29. Hematopoietic Stem Cells3▲ 41×3 topics
  30. Mammalian Cells3▲ 107×1 topic
  31. Recombinant Protein3▲ 107×1 topic
  32. Transplant Recipients3▲ 49×2 topics
  33. Antiretroviral Therapy3▲ 17×3 topics
  34. Clinical Trials3▲ 6.5×4 topics
  35. Metastasis3▲ 11×4 topics
  36. Infection3▲ 13×3 topics
  37. Immunity3▲ 10×4 topics
  38. RNA Interference3▲ 30×1 topic
  39. siRNA Delivery3▲ 45×1 topic
  40. Congenital Infection3▲ 71×1 topic

Which research topics does MolMed (Italy) publish most on?

By volume in 2022–2025: Immune cells in cancer, Inflammation biomarkers and pathways, Simulation Techniques and Applications and Robotic Path Planning Algorithms.

  1. 1 Immune cells in cancer Immunology 0 works
  2. 2 Inflammation biomarkers and pathways Immunology 0 works
  3. 3 Simulation Techniques and Applications Management Science and Operations Research 0 works
  4. 4 Robotic Path Planning Algorithms Computer Vision and Pattern Recognition 0 works
  5. 5 Reinforcement Learning in Robotics Artificial Intelligence 0 works
  6. 6 Cholesterol and Lipid Metabolism Surgery 0 works
  7. 7 Immunotherapy and Immune Responses Immunology 0 works
  8. 8 Immune Cell Function and Interaction Immunology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.7%not open59.3%

World: 28% of research is openly available.

with international co-authors25.4%domestic only74.6%

World: 19% is written across borders.

How has MolMed (Italy)'s research output changed?

Output in 2018–2022 was 79% lower than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Milan

All research institutions in Milan

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.